Cargando…

Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson’s Disease

Rasagiline mesylate (RSM) is a hydrophilic drug with poor oral bioavailability (36%) because of hepatic first-pass metabolism. The present study focuses on delivering RSM directly to the brain through its inclusion within transferosomal in situ gel administered through the intranasal (IN) route. Tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	ElShagea, Hala N., Makar, Rana R., Salama, Alaa H., Elkasabgy, Nermeen A., Basalious, Emad B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967009/ https://www.ncbi.nlm.nih.gov/pubmed/36839855 http://dx.doi.org/10.3390/pharmaceutics15020533

Ejemplares similares

Curcumin Transferosome-Loaded Thermosensitive Intranasal in situ Gel as Prospective Antiviral Therapy for SARS-Cov-2
por: Eleraky, Nermin E, et al.
Publicado: (2023)

Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles
por: Kammoun, Ahmed K., et al.
Publicado: (2021)

Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson’s disease
por: Jiang, Ying, et al.
Publicado: (2017)

Curcumin modulation of L-dopa and rasagiline-induced neuroprotection in rotenone model of Parkinson’s disease
por: El-Shamarka, Marwa El-Sayed, et al.
Publicado: (2023)

Rasagiline in treatment of Parkinson’s disease
por: Nayak, Lakshmi, et al.
Publicado: (2008)

The neuroprotective agent Rasagiline mesylate attenuates cardiac remodeling after experimental myocardial infarction
por: Varela, Aimilia, et al.
Publicado: (2017)

Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation
por: Omar, Mahmoud M, et al.
Publicado: (2019)

Effect of the moist-heat sterilization on fabricated nanoscale solid lipid particles containing rasagiline mesylate
por: Viveksarathi, K., et al.
Publicado: (2015)

Dual-Drug Delivery via Zein In Situ Forming Implants Augmented with Titanium-Doped Bioactive Glass for Bone Regeneration: Preparation, In Vitro Characterization, and In Vivo Evaluation
por: Eldeeb, Alaa Emad, et al.
Publicado: (2022)

Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation [Retraction]
Publicado: (2022)

The role of rasagiline in the treatment of Parkinson’s disease
por: Leegwater-Kim, Julie, et al.
Publicado: (2010)

Rasagiline Withdrawal Syndrome in Parkinson’s Disease
por: Solla, Paolo, et al.
Publicado: (2022)

Thin film hydration versus modified spraying technique to fabricate intranasal spanlastic nanovesicles for rasagiline mesylate brain delivery: Characterization, statistical optimization, and in vivo pharmacokinetic evaluation
por: Ali, Mohamed Mahmoud, et al.
Publicado: (2022)

Biomaterials for Tissue Engineering Applications and Current Updates in the Field: A Comprehensive Review
por: Eldeeb, Alaa Emad, et al.
Publicado: (2022)

Adjunctive therapy in Parkinson’s disease: the role of rasagiline
por: Gaines, Kathryn D, et al.
Publicado: (2012)

Injectable Gamboge-Based In Situ Gel for Sustained Delivery of Imatinib Mesylate
por: Jitrangsri, Kritamorn, et al.
Publicado: (2023)

Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach
por: Ahmed, Osama AA, et al.
Publicado: (2018)

Design and evaluation of in situ gel eye drops containing nanoparticles of Gemifloxacin Mesylate
por: Kalaria, Vishwa J., et al.
Publicado: (2023)

From a Parkinson's disease expert: Rasagiline and the Future of Therapy
por: Lakhan, Shaheen E
Publicado: (2007)

Role of rasagiline in treating Parkinson’s disease: Effect on disease progression
por: Malaty, Irene A, et al.
Publicado: (2009)

Intranasal Zolmitriptan-Loaded Bilosomes with Extended Nasal Mucociliary Transit Time for Direct Nose to Brain Delivery
por: El Taweel, Mai M., et al.
Publicado: (2021)

Multi criteria decision making to select the best method for the preparation of solid lipid nanoparticles of rasagiline mesylate using analytic hierarchy process
por: Kunasekaran, Viveksarathi, et al.
Publicado: (2014)

Preparation and optimization of lidocaine transferosomal gel containing permeation enhancers: a promising approach for enhancement of skin permeation
por: Omar, Mahmoud M, et al.
Publicado: (2019)

Bee venom attenuates neurodegeneration and motor impairment and modulates the response to L-dopa or rasagiline in a mice model of Parkinson’s disease
por: Badawi, Hanaa MM, et al.
Publicado: (2020)

Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy
por: Lecht, Shimon, et al.
Publicado: (2007)

Rasagiline and Rapid Symptomatic Motor Effect in Parkinson’s Disease: Review of Literature
por: Pistacchi, Michele, et al.
Publicado: (2013)

Loratadine bioavailability via buccal transferosomal gel: formulation, statistical optimization, in vitro/in vivo characterization, and pharmacokinetics in human volunteers
por: Elkomy, Mohammed H., et al.
Publicado: (2017)

Calcium-Enriched Nanofibrillated Cellulose/Poloxamer in-situ Forming Hydrogel Scaffolds as a Controlled Delivery System of Raloxifene HCl for Bone Engineering
por: Kamel, Rabab, et al.
Publicado: (2021)

Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease
por: Petit, Géraldine H., et al.
Publicado: (2013)

Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
por: Schettino, Carla, et al.
Publicado: (2016)

Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study
por: Peretz, Chava, et al.
Publicado: (2016)

Rasagiline, sleep quality and well-being in Parkinson’s disease: a pilot study
por: Mutti, Carlotta, et al.
Publicado: (2022)

Preparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunction
por: Ali, Maha Fadel M, et al.
Publicado: (2015)

Protection Provided by a Gabexate Mesylate Thermo-Sensitive In Situ Gel for Rats with Grade III Pancreatic Trauma
por: Gao, Hanjing, et al.
Publicado: (2017)

Imatinib Mesylate-Loaded Rosin/Cinnamon Oil-Based In Situ Forming Gel against Colorectal Cancer Cells
por: Khaing, Ei Mon, et al.
Publicado: (2022)

Rasagiline does not exacerbate autonomic blood pressure dysregulation in early or mild Parkinson’s disease
por: Oka, Hisayoshi, et al.
Publicado: (2021)

Rasagiline as Adjunct to Levodopa for Treatment of Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Kano, Osamu, et al.
Publicado: (2022)

Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation
por: Rajan, Reshmy, et al.
Publicado: (2011)

Linoleic Acid-Based Transferosomes for Topical Ocular Delivery of Cyclosporine A
por: Uwaezuoke, Onyinye, et al.
Publicado: (2022)

Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery
por: Rashed, Hassan M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rm7hpf60ij08ft2qhofknr1ajj